⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AARD News
Aardvark Therapeutics, Inc. Common Stock
Pomerantz LLP Files Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Pomerantz LLP Moves Forward with Class Action Lawsuit Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
ROSEN, A GLOBALLY RESPECTED LAW FIRM, Encourages Aardvark Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AARD
accessnewswire.com
AARD
AARD Stockholders Have Rights – If You Lost Money Investing in Aardvark Therapeutics, Inc. Contact Robbins LLP for Information About Recovering Your Losses
businesswire.com
AARD
AARD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aardvark Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
AARD
AARD Investors Have Opportunity to Lead Aardvark Therapeutics, Inc. Securities Fraud Lawsuit with SBS Law
globenewswire.com
AARD
AARD DEADLINE NOTICE: Faruqi & Faruqi, LLP Reminds Aardvark (AARD) Investors of Securities Class Action Lawsuit Deadline on October 13, 2026 Ready to Announce with Confidence?
newsfilecorp.com
AARD
Pomerantz LLP Files Class Action Against Aardvark Therapeutics, Inc. – AARD
accessnewswire.com
AARD
Levi & Korsinsky Notifies Aardvark Therapeutics, Inc. (AARD) Investors - Lead Plaintiff Deadline on October 13, 2026
accessnewswire.com
AARD
Investors in Aardvark Therapeutics, Inc. (AARD): Protect Your Rights - Contact Levi & Korsinsky Before October 13, 2026
accessnewswire.com
AARD